Abstract: The specification relates to compounds of Formula (I): and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of diseases such as liver disease.

Abstract: The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: A method and associated system are provided for processing data to complete a collect telephone call to a called-party that has prepaid an account to pay for the collect call. Data is received regarding a collect call from a caller to the called-party. Next it is determining whether the called party is associated with a prepaid account and the rate to be applied to the collect call. The rate to be applied to the call is increased by a tax rate and the data is sent regarding the call rate to be applied to the collect call so that the call can be completed between the called party and caller.

Abstract: A method and apparatus for providing inmate security threat group information includes correlating inmate identification records from a plurality of correctional facilities in a central database with call detail records from inmate telephone activities together with security threat group data comprising inmate affiliations and telephone numbers associated with security threats and security threat groups.

Abstract: A computerized visitation registration and scheduling system provides the department of corrections the ability to have inmates and visitors schedule visits through an automated interface, such as a telephone interface, or the internet. The system allows, for example, the ability for potential visitors to perform a registration process with little to no manual overhead requirements of department of corrections employees. Secondly, potential visitors, once approved, are able to schedule inmate visits without necessarily having to burden department of corrections employees.

Abstract: A method and associated system are provided for processing data to complete a collect telephone call to a called-party that has prepaid an account to pay for the collect call. Data is received regarding a collect call from a caller to the called-party. Next it is determining whether the called party is associated with a prepaid account and the rate to be applied to the collect call. The rate to be applied to the call is increased by a tax rate and the data is sent regarding the call rate to be applied to the collect call so that the call can be completed between the called party and caller.

Abstract: A method and apparatus for providing inmate security threat group information includes correlating inmate identification records from a plurality of correctional facilities in a central database with call detail records from inmate telephone activities together with security threat group data comprising inmate affiliations and telephone numbers associated with security threats and security threat groups.